Comparison in symptoms between aged and younger patients with narcolepsy

Hisakazu Furuta, Michael J. Thorpy, Helen M. Temple

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

We investigated the age-related changes in symptoms in narcolepsy. Fifty patients, 65-year-old and over (aged group), were recruited from the National Narcolepsy Registry. Thirty-four patients, younger than 65 (younger group), were selected by random sampling. Although there was no difference in the age of disease onset between the two groups, the age of diagnosis was significantly earlier for the younger group. Methylphenidate was used significantly more in the aged group, and modafinil in the younger group. The aged group had lower total scores on the Ullanlinna Narcolepsy Scale, because the scores for cataplexy were significantly less for the aged group. There was no significant difference in excessive daytime sleepiness between the two groups.

Original languageEnglish (US)
Pages (from-to)241-242
Number of pages2
JournalPsychiatry and Clinical Neurosciences
Volume55
Issue number3
DOIs
StatePublished - 2001

Fingerprint

Narcolepsy
Cataplexy
Methylphenidate
Age of Onset
Registries
Age Groups

Keywords

  • Aging
  • Cataplexy
  • Narcolepsy
  • National Narcolepsy Registry
  • Ullanlinna Narcolepsy Scale

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Comparison in symptoms between aged and younger patients with narcolepsy. / Furuta, Hisakazu; Thorpy, Michael J.; Temple, Helen M.

In: Psychiatry and Clinical Neurosciences, Vol. 55, No. 3, 2001, p. 241-242.

Research output: Contribution to journalArticle

@article{42f0688b9bf14dd289426ef778ab8ac8,
title = "Comparison in symptoms between aged and younger patients with narcolepsy",
abstract = "We investigated the age-related changes in symptoms in narcolepsy. Fifty patients, 65-year-old and over (aged group), were recruited from the National Narcolepsy Registry. Thirty-four patients, younger than 65 (younger group), were selected by random sampling. Although there was no difference in the age of disease onset between the two groups, the age of diagnosis was significantly earlier for the younger group. Methylphenidate was used significantly more in the aged group, and modafinil in the younger group. The aged group had lower total scores on the Ullanlinna Narcolepsy Scale, because the scores for cataplexy were significantly less for the aged group. There was no significant difference in excessive daytime sleepiness between the two groups.",
keywords = "Aging, Cataplexy, Narcolepsy, National Narcolepsy Registry, Ullanlinna Narcolepsy Scale",
author = "Hisakazu Furuta and Thorpy, {Michael J.} and Temple, {Helen M.}",
year = "2001",
doi = "10.1046/j.1440-1819.2001.00841.x",
language = "English (US)",
volume = "55",
pages = "241--242",
journal = "Psychiatry and Clinical Neurosciences",
issn = "1323-1316",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Comparison in symptoms between aged and younger patients with narcolepsy

AU - Furuta, Hisakazu

AU - Thorpy, Michael J.

AU - Temple, Helen M.

PY - 2001

Y1 - 2001

N2 - We investigated the age-related changes in symptoms in narcolepsy. Fifty patients, 65-year-old and over (aged group), were recruited from the National Narcolepsy Registry. Thirty-four patients, younger than 65 (younger group), were selected by random sampling. Although there was no difference in the age of disease onset between the two groups, the age of diagnosis was significantly earlier for the younger group. Methylphenidate was used significantly more in the aged group, and modafinil in the younger group. The aged group had lower total scores on the Ullanlinna Narcolepsy Scale, because the scores for cataplexy were significantly less for the aged group. There was no significant difference in excessive daytime sleepiness between the two groups.

AB - We investigated the age-related changes in symptoms in narcolepsy. Fifty patients, 65-year-old and over (aged group), were recruited from the National Narcolepsy Registry. Thirty-four patients, younger than 65 (younger group), were selected by random sampling. Although there was no difference in the age of disease onset between the two groups, the age of diagnosis was significantly earlier for the younger group. Methylphenidate was used significantly more in the aged group, and modafinil in the younger group. The aged group had lower total scores on the Ullanlinna Narcolepsy Scale, because the scores for cataplexy were significantly less for the aged group. There was no significant difference in excessive daytime sleepiness between the two groups.

KW - Aging

KW - Cataplexy

KW - Narcolepsy

KW - National Narcolepsy Registry

KW - Ullanlinna Narcolepsy Scale

UR - http://www.scopus.com/inward/record.url?scp=0034990634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034990634&partnerID=8YFLogxK

U2 - 10.1046/j.1440-1819.2001.00841.x

DO - 10.1046/j.1440-1819.2001.00841.x

M3 - Article

C2 - 11422857

AN - SCOPUS:0034990634

VL - 55

SP - 241

EP - 242

JO - Psychiatry and Clinical Neurosciences

JF - Psychiatry and Clinical Neurosciences

SN - 1323-1316

IS - 3

ER -